secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bio Green Med Solution, Inc. (BGMS)
CIK:        0001130166
Form:       8-K
Filed at:   2024-12-12T23:59:59+00:00
Accession:  0001104659-24-128022
Event type: regulatory
Sentiment:  negative
Materiality: 0.85
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Cyclacel receives Nasdaq bid-price deficiency notice; stock at risk of delisting
--------------------------------------------------------------------------------

- Nasdaq notified Cyclacel on Dec 6, 2024, that common stock bid price below $1.00 for 30 consecutive business days.
- Company has 180 calendar days (until June 4, 2025) to regain compliance by closing at $1.00+ for 10 consecutive days.
- If not compliant by June 4, 2025, Nasdaq may delist common stock; company may appeal to hearings panel.
- Cyclacel is considering alternatives including a potential reverse stock split to meet the bid-price rule.
- Common stock continues trading on Nasdaq under symbol CYCC during the grace period.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1130166/000110465924128022/0001104659-24-128022-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1130166/000110465924128022/tm2430847d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-128022

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer